| 1/8 | US=40 / Gastro Carrilho FJ. Fatores de risco para o carcinoma hepatocelular. In: Habr-Gama A, Gama-Rodrigues J, Bresciani C, Ziberstein B, Kiss DR, Cecconello I, Cunha JEM, Saad WA, Bocchini SF. Atualizaçao em cirurgia do aparelho disgestivo e coloproctologia. São Paulo: Frôntis, 2005. p. 217-23. VIRUS DA HEPATITE B; VIRUS DA HEPATITE C; RELACAO COM O ALCOOL; CIRROSE |
| 2/8 | US=32 / Câncer Ambinder RF. Infectious etiology of lymphoma. In: Armitage JO, Mauch PM, Harris NL, Coiffer B, Dalla-Favera R. Non-Hodkin lymphomas. 2ªed. Philadelphia: J.B. Lippincott Company, 2010. p. 83-101. ISBN 978-0-7817-9116-8. LINFOMA INFECCIOSAS; LINFOMA INFECCIOSAS. ETIOLOGIA; TUMORES ESPECIFICOS; LINFOMA DE BURKITT; VIRUS DA HEPATITE C; VIRUS EPSTEIN-BARR |
| 3/8 | US=1 / Gastro Groopman JD, Brodovicz K, Kensler TW. Environmental carcinogens and risk for human liver cancer. In: Carr BI. Hepatocellular carcinoma: diagnosis and treatment. New York: Humana Press, 2010. p. 27-53. ISBN 978-1-60327-373-2. CARCINOGENOS AMBIENTAIS; CANCER DE FIGADO HUMANO. RISCOS; CARCINOMA HEPATOCELULAR; COLANGIOCARCINOMAS; CARCINOMAS DE VIAS BILIARES; VIRUS DA HEPATITE B; VIRUS DA HEPATITE C |
| 4/8 | US=66 / Câncer Zhu Q, Weiner AJ. A hepatitis C virus xenograft mouse efficacy model. In: Kozlov SV. Inflammation and cancer: methods and protocols: experimental models and practical approaches. New York: Humana Press, 2009. p. 323-31. (Methods in Molecular Biology n.511 - Springer Protocols) ISBN 978-1-934115-14-5. VIRUS DA HEPATITE C. XENOENXERTO; VIRUS DA HEPATITE C; MURINO; MODELO DE TUMOR; ANTIVIRAL; REPLICON |
| 5/8 | US=106 / Câncer LaFemina RL. Hepatitis C virus genetics and the discovery of mechanism-based inhibitors of the NS3/4A protease and NS5B polymerase. In: Nicholas J, Jeang K-T, Wu T-C. Human cancer viruses: principles of transformation and pathogenesis. Basel: Karger, 2008. p. 62-93. (Translation Research in Biomedicine) ISBN 978-3-805-58576-7. VIRUS DA HEPATITE C; MECANISMO; INIBIDORES DA PROTEASE; HEPATITE REPLICACAO DO VIRUS C; TERAPIA ANTIVIRAL ATUAL; VIRUS DA HEPATITE C NS3/4A PROTEASE |
| 6/8 | US=36 / Gastro Kelly CR, Wands JR. Molecular biology of liver carcinogenesis and hepatitis. In: Blumgart LH. Surgery of the biliary tract, and pancreas. 4th ed. Philadelphia: Elsevier Saunders, 2007. p. 153-63. (v.1) ISBN 978-1-4160-3256-8. BIOLOGIA MOLECULAR DE CARCINOGENESE DO FIGADO; BIOLOGIA MOLECULAR DE HEPATITE; VIRUS DA HEPATITE B; VIRUS DA HEPATITE C; P53 GENE SUPRESSOR DE TUMOR E AFLATOXINAS; TELOMERO ENCURTAMENTO; TRANSDUCAO DE VIAS DE SINALIZACAO |
| 7/8 | US=77-J / Câncer Sichero L, Rabachini T. Vírus e câncer. In: Lopes A, Chammas R, Iyeyasu H. Oncologia para a graduação. 3ª ed. São Paulo: Lemar, 2013. p. 62-9. ISBN 8-5866523-7-0. CANCER; VIRUS; CARCINOGENESE VIRAL; RETROVIRUS; HTLV-1; VIRUS LINFOTROPICO DE CELULAS T; HIV-1; VIRUS DA IMUNODEFICIENCIA ADQUIRIDA; HCV; VIRUS DA HEPATITE C; VIRUS DE DNA; HBV; VIRUS DA HEPATITE B; HPV; PAPILOMAVIRUS HUMANO; EBV; VIRUS EPSTEIN-BARR; HERPESVIRUS; SARCOMA DE KAPOSI; HERPESVIRUS HUMANO TIPO 8 |
| 8/8 | US=61 / Biol/Mol Silva CMD, Niel C. Hepatite C. In: Rossetti ML, Silva CMD, Rodrigues JJS. Doenças infecciosas: diagnóstico molecular. Rio de Janeiro: Guanabara-Koogan, 2006. p. 123-34. ISBN 85-2771083-8. HEPATITE C; VIRUS DA HEPATITE C; TRANSMISSAO DA HEPATITE C; DIAGNOSTICO MOLECULAR |